
Ro is a Virtual Care Delivery company founded in 2017 and based in New York, United States. It has raised $1.0B in total funding, most recently a Growth in 2022 at a $7B valuation.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Feb 15, 2022 | Growth | $150M | $7B | ShawSpring Partners |
| Mar 16, 2021 | Series D | $500M | $5B |
| General Catalyst, FirstMark Capital, TQ Ventures |
| Jul 27, 2020 | Series C | $200M | $1.5B | General Catalyst |
| Apr 15, 2019 | Series B | $85M | $500M | — |
| Sep 18, 2018 | Series A | $88M | — | FirstMark Capital |
| Nov 1, 2017 | Seed | $3.1M | — | General Catalyst |
ro.OS is Ro's proprietary technology platform that vertically integrates the core components of healthcare — telehealth, pharmacy, at-home lab testing, and diagnostics — into a single end-to-end system. It comprises a Patient App for messaging providers, tracking progress, and managing care; a Care Delivery App with an integrated EMR for clinicians; and a Pharmacy App connecting pharmacists directly into patient care workflows. ro.OS has facilitated tens of millions of treatments and hundreds of millions of care interactions across the United States.
Ro's comprehensive weight management program combines access to FDA-approved GLP-1 medications (such as Zepbound, Wegovy, and compounded semaglutide) with expert provider care, coaching, and app-based treatment. Patients receive personalized treatment plans, monthly check-ins, unlimited messaging with care teams, and assistance navigating insurance coverage for brand-name GLP-1s. The program differentiates itself through a holistic approach that pairs medication with lifestyle coaching to help patients achieve sustainable weight loss.
Ro's sexual health offering provides telehealth consultations and at-home delivery of treatments for erectile dysfunction, premature ejaculation, and other sexual health concerns. Patients complete an online consultation with a licensed provider and receive prescribed medications — including generic sildenafil, tadalafil, and branded options like Daily Rise Gummies — shipped discreetly to their door. The service emphasizes convenience, privacy, and ongoing provider support through unlimited messaging.
Ro's at-home diagnostic testing service enables patients to collect lab samples from home and receive results digitally through the Ro platform. The service covers a range of health markers including testosterone levels, thyroid function, cholesterol, and comprehensive metabolic panels. Tests are ordered by Ro-affiliated providers as part of a broader care plan, and results flow directly into the patient's ro.OS record so providers can adjust treatments accordingly, creating a闭环 between diagnosis and treatment.







